LLY compared with TRVI: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

TRVITrevi Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

TRVITrevi Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

TRVI

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±14.8%▲+0.05%×0.01

May 6 '26±8.2%▼−2.73%×0.33

= impliedLLY realized, solidTRVI realized, hatchedOne scale, both sides: full bar = 18%× = |realized| ÷ impliedspan: LLY 267d · TRVI 142dSource: market data

Apr 17 '26

±17.5%

▲+4.75%

×0.27

Q1 FY26±11.9%▼−4.47%×0.38

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

TRVITrevi Therapeutics, Inc.

14.33▲+11.87%· post 15.14

ClosedNov 6 '26

Mkt cap$2.0BRevenue—Revenue—

Compare

ClosedNov 6 '26

LLYELI Lilly & Co

TRVITrevi Therapeutics, Inc.

1,360.90▼−0.28%post 1,358.90

Price

14.33▲+11.87%post 15.14

$1.2T

Mkt cap

$2.0B

Q3 FY26$24.4B

Revenue

—

FY25$65.2B

Revenue

—

LLY1,360.90▼−0.28%vsTRVI14.33▲+11.87%ClosedNov 6 '26